Everything you ever wanted to know about hair bonds and bond-building products, including how Olaplex, K18, and other ...

Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug conjugate (ADC) linker platform.

Depending on your source of health news or the slant of your social media feed, you might be getting inundated these days with info about peptide therapy. This medical treatment involves using ...

Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...

Proteases are enzymes that catalyse hydrolysis of the peptide and isopeptide bonds that join amino acids within proteins (known as proteolysis). Proteases can also remove protein post ...

Taiho Pharma to buy next-generation ADC drug discovery company ,Araris Biotech: Japan Tuesday, March 18, 2025, 16:00 Hrs [IST] Taiho Pharmaceutical Co., Ltd., an R&D-driven specia ...

This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...

Birefringent crystalline materials are essential in advanced optical technologies such as isolators and modulators due to ...

For the first time scientists have identified promising drug candidates that bind irreversibly with a notoriously "undruggable" cancer protein target, permanently blocking it.

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...